These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma. Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224 [TBL] [Abstract][Full Text] [Related]
45. Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity: Gorunova L; Bjerkehagen B; Micci F; Heim S; Panagopoulos I Cancer Genomics Proteomics; 2020; 17(5):563-569. PubMed ID: 32859634 [TBL] [Abstract][Full Text] [Related]
46. Molecular diagnostics in the management of rhabdomyosarcoma. Arnold MA; Barr FG Expert Rev Mol Diagn; 2017 Feb; 17(2):189-194. PubMed ID: 28058850 [TBL] [Abstract][Full Text] [Related]
47. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature]. Zhu L; Wang J Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445 [TBL] [Abstract][Full Text] [Related]
48. Testicular fusocellular rhabdomyosarcoma as a metastasis of elbow sclerosing rhabdomyosarcoma: A clinicopathologic, immunohistochemical and molecular study of one case. Martorell M; Ortiz CM; Garcia JA Diagn Pathol; 2010 Aug; 5():52. PubMed ID: 20701800 [TBL] [Abstract][Full Text] [Related]
49. Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature. Balogh P; Bánusz R; Csóka M; Váradi Z; Varga E; Sápi Z Diagn Pathol; 2016 Oct; 11(1):99. PubMed ID: 27756397 [TBL] [Abstract][Full Text] [Related]
50. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis]. Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817 [No Abstract] [Full Text] [Related]
51. Histopathological classification of childhood rhabdomyosarcomas: relationship with clinical parameters and prognosis. Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Voute PA; Meijer CJ Hum Pathol; 1994 Sep; 25(9):900-7. PubMed ID: 8088765 [TBL] [Abstract][Full Text] [Related]
52. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621 [TBL] [Abstract][Full Text] [Related]
53. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Dias P; Parham DM; Shapiro DN; Webber BL; Houghton PJ Am J Pathol; 1990 Dec; 137(6):1283-91. PubMed ID: 2260621 [TBL] [Abstract][Full Text] [Related]
54. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases. Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123 [TBL] [Abstract][Full Text] [Related]
55. [Clinicopathological study of 145 childhood rhabdomyosarcoma cases]. He LJ; Wang L; Sun N; Huang CR; Zhu XD; Lang ZQ Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):225-8. PubMed ID: 15256113 [TBL] [Abstract][Full Text] [Related]
56. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases]. Yu L; Wang J Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377 [TBL] [Abstract][Full Text] [Related]
57. Spindle Cell/Sclerosing Rhabdomyosarcoma With Rakheja D; Park JY; Alhasan M; Uddin N Int J Surg Pathol; 2022 Dec; 30(8):950-955. PubMed ID: 35466752 [TBL] [Abstract][Full Text] [Related]
58. Establishment and characterization of NCC-ssRMS1-C1: a novel patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line. Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Iwata S; Sugiyama M; Yoshida A; Kawai A; Kondo T Hum Cell; 2020 Jul; 33(3):886-893. PubMed ID: 32300959 [TBL] [Abstract][Full Text] [Related]
59. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma. Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773 [TBL] [Abstract][Full Text] [Related]